164 related articles for article (PubMed ID: 33806217)
1. MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in
Feriancikova B; Feglarova T; Krskova L; Eckschlager T; Vicha A; Hrabeta J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806217
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of N‑Myc inhibits neuroblastoma cell growth via the Wnt/β‑catenin signaling pathway.
Wang Y; Gao S; Wang W; Xia Y; Liang J
Mol Med Rep; 2018 Jul; 18(1):377-384. PubMed ID: 29749516
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration.
Duijkers FA; Meijerink JP; Pieters R; van Noesel MM
Gene; 2013 May; 521(1):62-8. PubMed ID: 23523856
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing reveals a key role for the long non-coding RNA MIAT in regulating neuroblastoma and glioblastoma cell fate.
Bountali A; Tonge DP; Mourtada-Maarabouni M
Int J Biol Macromol; 2019 Jun; 130():878-891. PubMed ID: 30836187
[TBL] [Abstract][Full Text] [Related]
6. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
7. MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent.
Wang T; Liu L; Chen X; Shen Y; Lian G; Shah N; Davidoff AM; Yang J; Wang R
Cell Death Dis; 2018 Feb; 9(2):220. PubMed ID: 29445162
[TBL] [Abstract][Full Text] [Related]
8. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
9. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
10. MYCN induces neuroblastoma in primary neural crest cells.
Olsen RR; Otero JH; García-López J; Wallace K; Finkelstein D; Rehg JE; Yin Z; Wang YD; Freeman KW
Oncogene; 2017 Aug; 36(35):5075-5082. PubMed ID: 28459463
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
[TBL] [Abstract][Full Text] [Related]
12. Suppression of MYC by high expression of NMYC in human neuroblastoma cells.
Breit S; Schwab M
J Neurosci Res; 1989 Sep; 24(1):21-8. PubMed ID: 2810395
[TBL] [Abstract][Full Text] [Related]
13. Temporal Quantitative Proteomics Analysis of Neuroblastoma Cells Treated with Bovine Milk-Derived Extracellular Vesicles Highlights the Anti-Proliferative Properties of Milk-Derived Extracellular Vesicles.
Fonseka P; Kang T; Chee S; Chitti SV; Sanwlani R; Ang CS; Mathivanan S
Cells; 2021 Mar; 10(4):. PubMed ID: 33805332
[TBL] [Abstract][Full Text] [Related]
14. MYCN‑amplified neuroblastoma cell‑derived exosomal miR‑17‑5p promotes proliferation and migration of non‑MYCN amplified cells.
Chen W; Hao X; Yang B; Zhang Y; Sun L; Hua Y; Yang L; Yu J; Zhao J; Hou L; Lu H
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537818
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Infarction Associated Transcript (MIAT): Review of its impact in the tumorigenesis.
Ghafouri-Fard S; Azimi T; Taheri M
Biomed Pharmacother; 2021 Jan; 133():111040. PubMed ID: 33378948
[TBL] [Abstract][Full Text] [Related]
16. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Gene Network Analysis and Transcriptional Landscape of MYCN-Amplified Neuroblastoma Cell Lines.
Mercatelli D; Balboni N; Palma A; Aleo E; Sanna PP; Perini G; Giorgi FM
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33525507
[TBL] [Abstract][Full Text] [Related]
18. The role of long non-coding RNA MIAT in cancers.
Da CM; Gong CY; Nan W; Zhou KS; Wu ZL; Zhang HH
Biomed Pharmacother; 2020 Sep; 129():110359. PubMed ID: 32535389
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
Zhang C; Xie L; Liang H; Cui Y
IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
[TBL] [Abstract][Full Text] [Related]
20. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
